Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ä¡ÇÙ ¼ö¼ú Áß ³»°ý¾à±Ù°ú â»ó¿¡ ÁÖ»çÇÑ Tarasyn ÀÇ ÁøÅë È¿°ú Effects of Intraoperative Injection of Tarasyn for Pain Relief on Patients Undergoing Hemorrhoidectomy - Result of a prospective, randomized trial -

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2000³â 16±Ç 6È£ p.371 ~ 375
±è¹ÎÂù, ÃÖÈ«Á¶,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¹ÎÂù ( Kim Min-Chan ) 
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

ÃÖÈ«Á¶ ( Choi Hong-Jo ) 
µ¿¾Æ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: The aim of this prospective study was to evaluate whether additional intraoperative injection of Tarasyn (ketorolac tromethamine) provided a preemptive analgesic effect that improved postoperative pain.

Methods: Sixty patients scheduled for hemorrhoidectomy were randomly assigned to the study and control groups. For the control group (n=32), patients were treated with standard intravenous injections of Nubain (Nalbuphine hydrochloride; Jeil Pharmaceuticals Co, Seoul) per 8 hours for three times postoperatively for pain relief. In the study group (Tarasyn group, n=28), 60 mg of Tarasyn (ketorolac tromethamine; Roche Korea, Seoul) was injected into the internal sphincter muscle and around the operative wound at the time of hemorrhoidectomy as well as standard intravenous injections of Nubain . Parameters were measured of pain score from 0 (no pain) to 10 (agonizing pain), painless sound sleep, additional analgesic requirements, time to first bowel movement, and postoperative urinary retention.

Results: Rate of painless sound sleep was 75.0% and 53.1% in the Tarasyn and the control groups, respectively, which was significant statically between two groups (P£¼0.05). Time to first bowel movement was 2 and 3.2 days in Tarasyn and the control groups, respectively, which was also significant statistically (P£¼0.05). Voiding difficulty developed in one case (3.5%) in the Tarasyn group and he needed catheterization. In the control group, however, the number (15 cases, 46.9%; P£¼0.001) was much higher requiring more catherization (13 cases, 40.9%; P£¼0.001). Mean pain scores was significant statically between two groups (P£¼0.001).

Conclusion: The data suggest that the use of intraoperative injection of Tarasyn is associated with a significant decrease in pain and urinary complications after hemorrhoidectomy.

Å°¿öµå

Ÿ¶ó½Å;Ä¡ÇÙÀýÁ¦¼ú;¼ö¼ú ÈÄ ÅëÁõ;¿ä·Î ÇÕº´Áõ
Tarasyn;Hemorrhoidectomy;Postoperative pain;Urinary complication

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS